ATE365326T1 - Verfahren zur analyse der menge an intraabdominalem fettgewebe - Google Patents

Verfahren zur analyse der menge an intraabdominalem fettgewebe

Info

Publication number
ATE365326T1
ATE365326T1 AT00915358T AT00915358T ATE365326T1 AT E365326 T1 ATE365326 T1 AT E365326T1 AT 00915358 T AT00915358 T AT 00915358T AT 00915358 T AT00915358 T AT 00915358T AT E365326 T1 ATE365326 T1 AT E365326T1
Authority
AT
Austria
Prior art keywords
tissue
animal
amount
protein
cell
Prior art date
Application number
AT00915358T
Other languages
English (en)
Inventor
Yuji Matsuzawa
Hiroko Murakami
Masako Nishizawa
Original Assignee
Sumitomo Chemical Co
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co, Dainippon Sumitomo Pharma Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of ATE365326T1 publication Critical patent/ATE365326T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
AT00915358T 1999-04-12 2000-04-06 Verfahren zur analyse der menge an intraabdominalem fettgewebe ATE365326T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10385899 1999-04-12

Publications (1)

Publication Number Publication Date
ATE365326T1 true ATE365326T1 (de) 2007-07-15

Family

ID=14365157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915358T ATE365326T1 (de) 1999-04-12 2000-04-06 Verfahren zur analyse der menge an intraabdominalem fettgewebe

Country Status (7)

Country Link
US (1) US6844163B1 (de)
EP (1) EP1169647B1 (de)
AT (1) ATE365326T1 (de)
AU (1) AU773675B2 (de)
CA (1) CA2366523C (de)
DE (1) DE60035267T2 (de)
WO (1) WO2000062073A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010772A1 (fr) * 2000-07-31 2002-02-07 Sumitomo Chemical Company, Limited Procede d'analyse de la teneur en graisses accumulees dans des adipocytes
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
CA2529510A1 (en) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
EP1708689A2 (de) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Zusammensetzungen zur behandlung oder verhinderung von adipositas und insulin-resistenten erkrankungen
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
JP2005213206A (ja) * 2004-01-30 2005-08-11 Iichiro Shimomura 糖代謝機能改善剤
AU2005262472B2 (en) * 2004-06-16 2011-10-27 President And Fellows Of Harvard College Methods and compositions for modulating bax-mediated apoptosis
US20090054255A1 (en) * 2004-07-01 2009-02-26 The Regents Of The University Of California Microfluidic devices and methods
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
US20190356621A1 (en) * 2018-05-17 2019-11-21 Koninklijke Philips N.V. Adapting silence periods for digital messaging

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1160566A (en) 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US5693489A (en) 1984-03-30 1997-12-02 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
JP2581180B2 (ja) 1988-07-29 1997-02-12 株式会社明電舎 時刻情報伝送方式
IL107642A0 (en) * 1992-11-20 1994-02-27 Amgen Inc Progenitor b cell stimulating factor
US5861485A (en) 1994-08-23 1999-01-19 Millennium Pharmaceuticals, Inc. Polypeptides involved in body weight disorders, including obesity

Also Published As

Publication number Publication date
EP1169647B1 (de) 2007-06-20
DE60035267T2 (de) 2008-02-21
US6844163B1 (en) 2005-01-18
EP1169647A1 (de) 2002-01-09
AU3670400A (en) 2000-11-14
WO2000062073A1 (en) 2000-10-19
CA2366523C (en) 2008-10-14
DE60035267D1 (de) 2007-08-02
CA2366523A1 (en) 2000-10-19
AU773675B2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE117437T1 (de) Test von einer körperflüssigkeit zur messung von knochenresorption.
ATE365326T1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DE69841989D1 (de) Verfahren zur Bestimmung von Nukleinsäuresequenzen in Urin
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
DE69821246D1 (de) Testverfahren für collagenpeptid
CA2317816A1 (en) Peptide detection method
ES534023A0 (es) Mejoras introducidas en un metodo de inmunoensayo para determinar una yodotironina en un fluido biologico
DE69900998T2 (de) Verfahren zur diagnose adenokarzinom oder benigne pathologie der vorsteherdrüse
ATE433571T1 (de) Methode zur diagnose von nierenerkrankungen
BRPI0408067A (pt) disgnóstico de autismo
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
BR0308095A (pt) Teste para anticorpos anti-ingap
CA2588614A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
MXPA03009778A (es) Pepetido de union de anticuerpos de la enfermedad de crohn y metodo de examinar la enfermedad de crohn.
DK0973887T3 (da) Porcin leptin-protein, nukleinsyresekvenser, som koder herfor, og anvendelser heraf
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika
DE60238055D1 (de) Verfahren zur diagnose einer person mit multipler sklerose
ATE348840T1 (de) Verfahren zur prävention einer durch gefrieren induzierten abnahme der aktivität eines proteins
DE69121877T2 (de) Verfahren zur Messung der Aktivität angiotensinkonvertierenden Enzyms in biologischen Proben
ATE283479T1 (de) Verfahren und testsatz zur bestimmung der analytkonzentration im blut
Martin et al. A comparative study of the citrate and lactate concentrations in stains from semen, vaginal secretion and mixtures of the two using isotachophoresis
EP1436624A4 (de) Diagnose- und behandlungsverfahren sowie dafür geeignete mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties